Clinical Genetics Educational external assessment (EQA)- assuring improvement in the Clinical Service |
|
The common sense model of self-regulation and psychological adjustment to predictive genetic testing: a prospective study |
|
The counselees' self-reported request for psychological help in genetic counseling for hereditary breast/ovarian cancer: not only psychopathology matters |
|
The counsellees' view of an unclassified variant in BRCA1/2: recall, interpretation, and impact on life. |
|
Differences and similarities in breast cancer risk assessment models in clinical practice: which model to choose? |
|
Disentangling the Babylonian speech confusion in genetic counseling: an analysis of the reliability and validity of the nomenclature for BRCA1/2 DNA-test results other than pathogenic |
|
DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers |
|
Do BRCA1/2 mutation carriers have an earlier onset of natural menopause? |
|
E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium. |
|
The effectiveness of a graphical presentation in addition to a frequency format in the context of familial breast cancer risk communication: a multicenter controlled trial |
|
Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2. |
|
Exome sequencing of germline DNA from non-BRCA1/2 familial breast cancer cases selected on the basis of aCGH tumor profiling |
|
Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK). |
|
External quality assessment of clinical genetics from pilot assessment to full EQA scheme |
|
Familial breast cancer: is it time to move from a reactive to a proactive role? |
|
Family communication matters: the impact of telling relatives about unclassified variants and uninformative DNA-test results. |
|
A family history of breast cancer will not predict female early onset breast cancer in a population-based setting |
|
FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor |
|
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes |
|
General Practitioners and Breast Surgeons in France, Germany, Netherlands and the UK show variable breast cancer risk communication profiles |
|
Genetic counselling and the intention to undergo prophylactic mastectomy: effects of a breast cancer risk assessment |
|
Genetic testing for familial/hereditary breast cancer-comparison of guidelines and recommendations from the UK, France, the Netherlands and Germany |
|
Genome-wide linkage scan in Dutch hereditary non-BRCA1/2 breast cancer families identifies 9q21-22 as a putative breast cancer susceptibility locus. |
|
Genomewide high-density SNP linkage analysis of non-BRCA1/2 breast cancer families identifies various candidate regions and has greater power than microsatellite studies |
|
Guidance Statement On BRCA1/2 Tumor Testing in Ovarian Cancer Patients |
|
Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers |
|
Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics |
|
How women with a family history of breast cancer and their general practitioners act on genetic advice in general practice: prospective longitudinal study |
|
The impact of next generation sequencing on the analysis of breast cancer susceptibility: a role for extremely rare genetic variation? |
|
International variation in physicians' attitudes towards prophylactic mastectomy - comparison between France, Germany, the Netherlands and the United Kingdom. |
|
Large-scale genotyping identifies 41 new loci associated with breast cancer risk |
|
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification |
|
Little value from including cousins in individual risk assessment of hereditary breast cancer: a simulation study |
|
The MDM2 Promoter SNP285C/309G Haplotype Diminishes Sp1 Transcription Factor Binding and Reduces Risk for Breast and Ovarian Cancer in Caucasians |
|
Meaning-centered group psychotherapy in cancer survivors: a feasibility study. |
|
Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers |
|
Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls |
|
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer |
|
Mutational Spectrum in a Worldwide Study of 29,700 Families with BRCA1 or BRCA2 Mutations. |
|
Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. |
|
Omgaan met erfelijke kanker: advies geven en keuzes laten |
|
Opening the psychological black box in genetic counseling. The psychological impact of DNA testing is predicted by the counselees' perception, the medical impact by the pathogenic or uninformative BRCA1/2-result |
|
Pathological characterisation of male breast cancer: Results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program |
|
Perceiving cancer-risks and heredity-likelihood in genetic-counseling: how counselees recall and interpret BRCA 1/2-test results |
|
Possible consequences of applying guidelines to healthy women with a family history of breast cancer. |
|
Prediction of breast cancer risk based on profiling with common genetic variants |
|
Prognostic factors for hereditary cancer distress six months after BRCA1/2 or HNPCC genetic susceptibility testing |
|
A prospective study of the impact of genetic susceptibility testing for BRCA1/2 or HNPCC on family relationships |
|
Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition. |
|
Psychological factors associated with the intention to choose for risk-reducing mastectomy in family cancer clinic attendees |
|
Putting it all behind: long-term psychological impact of an inconclusive DNA test result for breast cancer. |
|
Recommendations for reporting results of diagnostic genomic testing |
|
Relevance and efficacy of breast cancer screening in BRCA1 and BRCA2 mutation carriers above 60 years: a national cohort study. |
|
The requirements of a specialist Breast Centre. |
|
Risk estimation for healthy women from breast cancer families: new insights and new strategies |
|
Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042. |
|
Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers |
|
Screening for familial ovarian cancer: poor survival of BRCA1/2 related cancers. |
|
Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study |
|
Timing of risk reducing mastectomy in breast cancer patients carrying a BRCA1/2 mutation: retrospective data from the Dutch HEBON study |
|
Transcriptome-wide association study of breast cancer risk by estrogen-receptor status |
|
Tumour characteristics and prognosis of breast cancer patients carrying the germline CHEK2*1100delC variant |
|
Urologists' and GPs' knowledge of hereditary prostate cancer is suboptimal for prostate cancer counseling: a nation-wide survey in The Netherlands |
|
Validation of a scale for assessing attitudes towards outcomes of genetic cancer testing among primary care providers and breast specialists |
|
Value-based healthcare in Lynch syndrome |
|
Variants of uncertain significance in BRCA1 and BRCA2 assessment of in silico analysis and a proposal for communication in genetic counselling |
|
Variation in mutation spectrum partly explains regional differences in the breast cancer risk of female BRCA mutation carriers in the Netherlands |
|
What's the message? Interpretation of an uninformative BRCA1/2 test result for women at risk of familial breast cancer. |
|
A whisper-game perspective on the family communication of DNA-test results: a retrospective study on the communication process of BRCA1/2-test results between proband and relatives |
|
Whole exome sequencing suggests much of non-BRCA1/BRCA2 familial breast cancer is due to moderate and low penetrance susceptibility alleles |
|